Global Medicines Program
Newsletter Archive
Newsletter archive:
FDA MEDWATCH NEWSFEED
- Risks with Exactech Joint Replacement Devices with Defective Packaging – FDA Safety Communication
- 2023 Safety Communications
- UPDATE: Reports of Squamous Cell Carcinoma (SCC) in the Capsule Around Breast Implants - FDA Safety Communication
- Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity